Integrated Life Cycle Patient Access Solutions that Maximize Brand ROI
|
|
- Maud Mathews
- 7 years ago
- Views:
Transcription
1 Integrated Life Cycle Patient Access Solutions August 2013 Bob Hastings Vice President of Marketing Contact: Mark Droke Senior Vice President, Business Development trialcard.com
2 Integrated Life Cycle Patient Access Solutions Pharmaceutical brand marketers are facing a paradigm shift in the way they market patient access solutions. As they navigate through the dynamics of a regionalized market, shrinking budgets and the challenges of tactical implementation, they require a consultative relationship with vendor providers. Can the pharmaceutical marketer really rely on one (1) vendor to deliver customized, innovative solutions over the life of their brand? What is Life-Cycle Marketing? The life-cycle of a pharmaceutical brand ranges from a detailed pre-launch stage and transitions through launch, growth, maturity and a patent expiration. Because of a relatively short time window for pharmaceutical brands to recoup the high-cost of research and development, it is imperative for brand teams to employ specific marketing strategies during the entire life-cycle of the brand to drive market share and recover their expenditures. The concept of product life-cycle marketing is a series of marketing strategies used by many pharmaceutical companies set in place to maximize brand performance over the course of its life-cycle. Specifically, the life-cycle refers to the commercial management of a product with respect to brand goals, strategies, tactics, costs and overall return on investment (ROI). Life-cycle marketing integrates people, data and business systems to provide a product information backbone for companies and their extended brand enterprise. The internal and external variables associated with brand promotion changes over time. In order to maximize ROI the employment of strategies and tactics must follow suit. The challenge to effectively implement a life-cycle strategy lies in the fact that traditional marketing strategies are segmented by brand life-cycle, inherent changes to personnel and changes to corporate revenue needs. Subsequently, today s brand is required to deliver year over year results while navigating a non-integrated life cycle. Over its life cycle, the traditional brand is managed by an average of 20 brand managers, has been asked to deliver 15 different goals and has 25 different sets of budget. This does not consider the impact associated with multiple changes in corporate and therapeutic leadership. In light of this, we have to ask ourselves where anchor tenants for brand success reside. Pharmaceutical Brand Partnership with Patient Access Providers You re probably asking yourself if you read the previous heading correctly. A patient access vendor is the answer to the brand s lifecycle needs? Yes, if the vendor has the insight and perspective into the brands needs as well as the innovative muscle to supply a pipeline of solutions throughout a brands lifecycle.
3 Patient access is no longer a one size fits all challenge. The ideal patient access partner must have an in-depth level of experience in providing innovative solutions that span across the life-cycle of the brand. They must also have a culture where the client needs are a corporate focal point. Consider the breadth and depth of experience a patient access provider has in working with 200+ brands and 300+ programs over the span of 12 years and you will quickly conclude that the patient access provider is, in fact a perfect lifecycle partner. Consider brand needs and goals for the 3 phases of its lifecycle, launch (= trial), growth (= loyalty), and maturity (= loyalty and preparation for LOE). Further, innovative problem solving must answer the needs of the prescriber / point of care, the pharmacist / point of sale and the patient / access to prescribed therapy. Overlay the challenges associated with a wide diversity of managed care formulary coverage, prior authorization, adherence and compliance and year on year achievement of forecast and it sets up a need for a consistent contributor who successfully navigates challenges and provides solutions. Equally important is a patient access solution provider who can partner with the brand team to provide a robust offering of data and analytical services. These may include the ability to conduct regional co-pay analyses, ROI studies, MD targeting, price elasticity and persistence reports. A comprehensive suite of analytical solutions coupled with highly-experienced patient access professionals will deliver significant results for the pharmaceutical brand for the life of the product. Partnering With the Pharmaceutical Brand Manager The brand manager vendor relationship must take the shape of a full scale partnership. Consider the fact that Brand managers are charged with initiating trial (launch), generating loyalty (maturity) and ultimately creating pull-through after the prescription is written which ultimately drives market share and revenue growth. Overlay the number of changes in brand personnel and you see a non-integrated and or incongruent development of brand strategies and tactical execution. Unless the provider is fully engaged as a problem solving partner, there is likelihood that tactical support will be short lived and deliver low results and even lower ROI. Utilizing a vendor / brand consultative approach incorporates a client provider philosophy which includes considerable knowledge of the pharmaceutical brand marketing strategy, brand goals (launch maturity), marketplace, product pricing, positioning and competitors within the marketplace. Patient access providers along with brand managers will benefit by regularly meeting, planning and consulting to discuss strategic initiatives designed to drive market share, improve patient access to their brands and provide a positive return on investment. Thereby, a typical pharmaceutical brand manager is interested in solution providers who: Offer comprehensive, innovative, time tested, product and service packages Functions as a subject matter expert within their own business space Assist in solving secondary problems directly related to the product or service being purchased Are creative, forward thinking and continuously develop new and innovative ideas year after year Maintain the brand managers budget Understand the pharmaceutical industries corporate guidelines and the ability to pass medical, legal, regulatory scrutiny Maintain an targeted ROI for the duration of the strategy
4 Integrated Life Cycle Patient Access Solutions Strategies for the Different Stages of the Product Life-Cycle The product life-cycle of a typical pharmaceutical product is somewhat similar to other consumer products in the marketplace. However, as illustrated in Figure 1 below, the addition of a pre-launch phase assists the pharmacy access provider to offer valuable information and strategies to the client prior to launch. Pre-Launch Phase Once a commercial marketing team is assembled prior to approval, strategy meetings take place to identify the market prior to launch. Included in those pre-launch strategy sessions are insight into best practices designed to address managed care access, competitive positioning, pricing, physician and patient behavioral change. These life-cycle marketing strategies also include an effort to maintain medication adherence for the patient. The patient access provider s value is represented in the insight, perspective and overall experience across comparable markets, brands and therapeutic areas. Thereby, the best opportunity to develop a life-cycle solution strategy is to partner with the pharmaceutical launch team prior to their brand receiving their label from the FDA. This partnering opportunity can occur as early as 6-12 months prior to the launch of the brand. This long runway allows the patient access provider to partner with the pharmaceutical brand team as a strategic subject matter expert in the area of patient access management for the duration of the products life-cycle. By partnering with customers in the early stage of the product approval process, pharmacy access providers can design a comprehensive life-cycle plan to assist physicians and patients in gaining access to medications. Additionally, the pre-launch phase allows the patient access provider to: Share best practices Review pharmacy solutions from similar products Identify the patient base Evaluate socio-economic factors Weigh geographic segmentation Assess competitors Project return on investment
5 About TrialCard Incorporated TrialCard Incorporated provides a comprehensive portfolio of Marketing for Patient Access, Prescription Abandonment, HUB/Reimbursement, Analytics, and Customer Experience Management. Since opening its doors in 2001, TrialCard has been awarded nine patents related to the processing and marketing of patient access programs. TrialCard is the largest provider of patient access programs in the industry, processing over $1 billion in patient benefits per year to help brand manufacturers achieve their goals with prescribers, patients, and pharmacists. For more information on TrialCard, please visit Contact: Mark Droke Senior Vice President, Business Development mark.droke@trialcard.com trialcard.com
Integrated Life Cycle Patient Access Solutions that Maximize Brand ROI
Integrated Life Cycle Patient Access Solutions that Maximize Brand ROI August, 2013 Bob Hastings Vice President of Marketing Pharmaceutical brand marketers are facing a paradigm shift in the way they market
More informationPfizer Struggles to Maintain Lipitor Sales Will Aggressive Discounting and Rebating Pay Off?
Pfizer Struggles to Maintain Lipitor Sales Will Aggressive Discounting and Rebating Pay Off? Research February 6, 2012 Rusty Jones Companies: Pfizer (PFE) Ranbaxy (OTC: RBXZF) Watson (WPI) Products: Lipitor
More informationSession 4: Understanding Data Behind the Complex New World of Health Care Involving IDNs and ACOs. Laura Jenkins Jirele
Session 4: Understanding Data Behind the Complex New World of Health Care Involving IDNs and ACOs Laura Jenkins Jirele PMSA Virtual University PMSA Virtual University is conducting this four part webinar
More informationOutsourcing in a Changing Environment
Outsourcing in a Changing Environment Commercial Solutions from Quintiles Copyright 2013 Quintiles Objectives Discuss the evolution of outsourcing Do cost efficiencies, i i flexibility and productivity
More informationMaking the Most of Property
the High performance portfolio: Making the Most of Property Management Agreements SUMMARY Property management agreements create the framework for who does what, when, where, and for how much in the relationship
More informationIntegrated Market Research: The Intelligence Behind Commercial Transformation
Cognizant 20-20 Insights Integrated Market Research: The Intelligence Behind Commercial Transformation To perform effectively in today s challenging economic conditions, pharma companies are weaving primary
More informationSpeeding Time to Market, Increasing Time in Market & Maintaining Market Velocity
Speeding Time to Market, Increasing Time in Market & Maintaining Market Velocity Best Practices in Driving Top-Line Growth Through Innovation & Collaboration Table of Contents 1 Introduction: The Need
More informationVirtual Brand Management: Optimizing Brand Contribution
Cognizant Solution Overview Virtual Brand Management: Optimizing Brand Contribution The Challenge The pharmaceuticals industry today is facing nothing short of a crisis. For starters, a reduced number
More informationCUSTOMER ATTAINMENT FROM EVENT ENGAGEMENT. EXECUTIVE SUMMARY April 2013
CUSTOMER ATTAINMENT FROM EVENT ENGAGEMENT EXECUTIVE SUMMARY April 2013 Copyright CMO Council. All Rights Reserved. 2013 ABSTRACT Change and transformation have become common occurrences if not required
More informationCall Planning that Delivers on Brand Strategy
SALES FORCE EFFECTIVENESS SUPPLEMENT Call Planning that Delivers on Brand Strategy New Information Sources Determine Prescriber Value BY MATTHEW LINKEWICH AND JAY MARGOLIS, IMS HEALTH The challenge of
More informationGlobal Big Data Market: Trends & Opportunities (2014-2019) June 2015
Global Big Data Market: Trends & Opportunities (2014-2019) June 2015 Scope of the Report The report titled Global Big Data Market: Trends and Opportunities (2014-2019), analyzes the potential opportunities
More informationCOGENT CONSULTING, INC.
COGENT CONSULTING, INC. point of view Taking the Guesswork out of Resource Allocation How to align marketing investments with growth opportunities and potential Doing More with Less The Patent Cliff. The
More informationPrescription drug costs continue to rise at
Prescription Drugs Developing an Effective Generic Prescription Drug Program by John D. Jones Pharmacy benefit managers (PBMs) use a variety of pricing strategies. When employers have a thorough knowledge
More informationDrive growth. See results. Performance Marketing Services Overview
Drive growth. See results. Performance Marketing Services Overview Channel agnostic portfolio management designed with your goals in mind. Channels don t matter to the customer; they engage with brands
More informationInertial loyalist: Has been satisfied with services received. Does not believe a better offer is available in the marketplace. Renews contract without
PBM Marketing and Sales Practice PBM Marketing & Sales Practice Building a Retention Strategy around Client Loyalty Categories March 2003 Todd Gibson PhD, Director and Practice Leader PBM Marketing and
More informationSession 2: Digging Deeper APLD, EMR, and Specialty Data Laura Jenkins Jirele
Session 2: Digging Deeper APLD, EMR, and Specialty Data Laura Jenkins Jirele PMSA Virtual University PMSA Virtual University is conducting this 4 part webinar series focused on the introduction and understanding
More informationKeys to success in multi-channel marketing in Japan
Keys to success in multi-channel marketing in Japan Abstract In the US and Europe, we have seen a drastic decline in the number of MRs and a rapid shift towards non-traditional multi-channel marketing
More informationRemove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach
Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach When it comes to supporting the clinical and marketing objectives of any pharmaceutical franchise, helping to remove
More informationOverview of the Specialty Drug Trend
WHITE PAPER Overview of the Specialty Drug Trend Succeeding In The Rapidly Changing U.S. Specialty Market 1 Specialty drugs are prescribed to treat complex conditions such as cancer, HIV and inflammatory
More informationPharmaceuticals CRM and Business Intelligence Reporting
Pharmaceuticals CRM and Business Intelligence ing Feb 2011 Rev: 1.0 1 SalesPharma is a Canadian Pharmaceuticals CRM Technology and Consulting Company with strong local presence in the MENA region. The
More informationBest Practices in Implementing CRM Solutions
Best Practices in Implementing CRM Solutions By Sanjeev Kumar, The Athene Group, LLC Reprint from September 2013 The focus on CRM solutions for the industry is higher than ever before. The evolution of
More informationUNDERSTANDING YOUR HEALTH NET PHARMACY BENEFITS Los Angeles Unified School District Learning about your pharmacy benefits can save you time and money
UNDERSTANDING YOUR HEALTH NET PHARMACY BENEFITS Los Angeles Unified School District Learning about your pharmacy benefits can save you time and money HEALTH NET MAKES USING YOUR NEW PHARMACY PLAN TROUBLE-FREE
More informationOverview of the BCBSRI Prescription Management Program
Definitions Overview of the BCBSRI Prescription Management Program DISPENSING GUIDELINES mean: the prescription order or refill must be limited to the quantities authorized by your doctor not to exceed
More informationShare a Clear View PHARMACY BENEFIT
Share a Clear View PHARMACY BENEFIT Share a Clear View NAVITUS CUSTOMER CARE HOURS: 24 Hours a Day 7 Days a Week 866-333-2757 (toll-free) TTY (toll-free) 711 MAILING ADDRESS: Navitus Health Solutions P.O.
More informationVirtual Detailing in Life Science Organizations
Healthcare Virtual Detailing in Life Science Organizations Table of Contents Problem Summary Pharmaceutical Life Science Product Sales The Deteriorating Dynamics Life Science Sales & Marketing: Between
More informationPreparing a New Dermatologic Agent for Market Launch. March, 2011
Preparing a New Dermatologic Agent for Market Launch March, 2011 The Situation A major pharmaceutical company sought to better understand how physicians treat patients with moderate to severe psoriasis
More informationStrategic Consulting Services
Services 1 Leadership Team Mark Levonyak President mlevonyak@davaonc.com Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services mlee@davaonc.com Mobile: 952.373.1405 John Eckardt, MD Chief
More informationFormulary Management Best Practices
Formulary Management Best Practices Introduction The drug formulary has served as the cornerstone for the administration of prescription drug benefits provided by managed care plans for more than thirty
More informationSelecting the Right Call Center Partner
Text for a pull out can go heretext for a pull out can go heretext for a pull out can go Text for a pull out can go here Text for a pull out can go here Selecting the Right Call Center Partner Nine Tips
More informationTranslating to the language of payers
Translating to the language of payers Actuarial analyses of new drug therapies Gregory Warren, FSA, MAAA Vice President, Pharmacy Actuarial Consulting 303-714-1022 gregory.warren@optum.com 1 Why are actuaries
More informationBuilding Supply Chain Capabilities in the Pharmaceutical Industry Part 1: Trends impacting the supply chain
Building Supply Chain Capabilities in the Pharmaceutical Industry Part 1: Trends impacting the supply chain UPS Supply Chain Solutions SM Copyright 005 United Parcel Service of America, Inc. All Rights
More informationOncology s $5 Billion Opportunity: Oncology Companies Can Improve the Customer Experience
Oncology s $5 Billion Opportunity: Oncology Companies Can Improve the Customer Experience The 2015 ZS Oncology Customer Experience Tracker Jon Roffman, Sankalp Sethi and Pranav Srivastava Oncology s $5
More informationJuly 2015. New Entrants: Charting the Health Industry s Risk and Regulatory Landscape Where Risk Meets Opportunity
July 2015 New Entrants: Charting the Health Industry s Risk and Regulatory Landscape Where Risk Meets Opportunity The new health economy is bringing change and new entrants from diverse industries are
More information5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned
PHARMACY WHAT S AN EMPLOYER TO DO? MAY 15, 2015 Debbie Doolittle Nashville, TN Pharmaceutical Spending Per Capita, 2013 vs. 2018 The US vs. the Rest of the World 1 Current Pharmacy Landscape How Did We
More informationHCSP GUIDES A GUIDE TO: PREPARING FOR TREATMENT. A publication of the Hepatitis C Support Project
HCSP GUIDES T R E AT M E N T I S S U E S A publication of the Hepatitis C Support Project The information in this guide is designed to help you understand and manage HCV and is not intended as medical
More informationUnlocking value across the payment continuum. Enhancing performance in a changing healthcare environment
Unlocking value across the payment continuum Enhancing performance in a changing healthcare environment For payers, accuracy is business-critical The entire healthcare system is increasingly focused on
More informationHow to Measure a Loyalty Programme s Return on Investment. Managing information and transactions securely
How to Measure a Loyalty Programme s Return on Investment Managing information and transactions securely Introduction Successful programmes have longevity because the overall benefits clearly justify the
More informationHow to Write a Marketing Plan
How to Write a Marketing Plan A Cowley Associates ebook Marketing is like all things in life. You can just wing it and be spontaneous. Or, you can plan things out ahead of time and have control over what
More informationPOST MARKET STUDY AS a SERVICE (PMSaaS) Chaitanya
www.hcltech.com POST MARKET STUDY AS a SERVICE (PMSaaS) AuthOr: Chaitanya WHITEPAPER November 2015 TABLE OF CONTENTS INTRODUCTION 3 WHY POST-LAUNCH MARKET STUDIES? 4 CHALLENGES IN CURRENT POST LAUNCH MARKET
More informationOverview, Goals, & Introductions
Improving the Retail Experience with Predictive Analytics www.spss.com/perspectives Overview, Goals, & Introductions Goal: To present the Retail Business Maturity Model Equip you with a plan of attack
More informationMedicare Part D Prescription Drug Coverage
Medicare Part D Prescription Drug Coverage Part 3 Version 7.1 August 1, 2013 Terms and Conditions This training program is protected under United States Copyright laws, 17 U.S.C.A. 101, et seq. and international
More informationCopyright 2009 SAS Institute Inc. All rights reserved. Success With Business Analytics in the New Pharmaceutical Commercial Model.
Copyright 2009 SAS Institute Inc. All rights reserved. Success With Business Analytics in the New Pharmaceutical Commercial Model. Emerging Commercial Models: Rethinking Analytics Deloitte Consulting LLP
More informationRMIP Prescription Plan FAQ's
RMIP Prescription Plan FAQ's A new U.S. Pharmacy Benefit Manager has been selected for January 1, 2015 - CVS/caremark. 1) Why is the RMIP changing to CVS/caremark? The Express Scripts contract ends on
More informationREMS: The New Reality
Kuyler Doyle, Principal Consultant, Campbell Alliance Jay Jauregui, Senior Practice Executive, Trade and Distribution Practice Gary Tyson, Senior Vice President, Clinical Development and Medical Affairs
More informationMedical affairs Driving influence across the health care ecosystem
Medical affairs Driving influence across the health care ecosystem Introduction Biopharmaceutical companies are aggressively pursuing strategies to remain competitive by developing and marketing innovative
More informationB2B Social Media Marketing Trends
B2B Social Media Marketing Trends Table of Contents. 3: Introduction 4: Most Important Objectives 5: Social Media Marketing Success 6: Challenging Obstacles to Success 7: How the Budget is Changing 8:
More informationProcess Optimization - Automation The First Step
Process Optimization - Automation The First Step Process Optimization - Automation: The First Step Business Process Management. To many, these words conjure up images of tremendous complexity. Months of
More informationMastering your supply spend
White Paper Mastering your supply spend Would you perform a procedure on a patient before validating eligibility for reimbursement? Of course you wouldn t. Then why not follow this same validation for
More informationPharmaceutical Business Plan Dawn Romvari-Mihalyi Cellular 917-208-7366
Pharmaceutical Business Plan Dawn Romvari-Mihalyi Cellular 917-208-7366 1.0 Executive Summary 2.0 Situation Analysis 2.1 Market Summary 2.1.1 Market Demographics 2.1.2 Market Needs 2.1.3 Market Trends
More informationMedicare Part D Prescription Drug Coverage
Medicare Part D Prescription Drug Coverage Part 3 Version 9.0 June 22, 2015 Terms and Conditions This training program is protected under United States Copyright laws, 17 U.S.C.A. 101, et seq. and international
More informationHow To Understand And Understand Biosimilars
Welcome to Biosimilars 20/20, presented by the Specialty Pharma Education Center (SPEC) in partnership with the Specialty Pharma Journal (SPJ). Please note that this is a preliminary agenda that is subject
More informationHow To Improve The Pharmaceutical Industry In Japanese
Pharmaceutical business innovation through utilization of EMR Abstract The pharmaceutical industry in Japan is in a transformation phase due to the government s tightening control over healthcare expenditure
More informationGrowth & Diversification
Market Diversification Program Forward-thinking business leaders regularly evaluate their products, capabilities, and customers. In today s rapidly changing economy, businesses must identify new markets
More informationU.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010
U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction
More informationAccelerate Performance in the New Era of Health Care. Innovate, adapt and grow
FICO Health care Solutions Accelerate Performance in the New Era of Health Care Innovate, adapt and grow The marketplace was requiring us to be more competitive to offer better electronic solutions to
More informationFundamentals Every B2B Marketer Must Know
Account-Based Marketing: Fundamentals Every B2B Marketer Must Know Demandbase.com Introduction If you re a B2B marketer today, you re in a tough spot. You d love to be an innovative marketer who impresses
More informationSession 3: The World of Big Data from the Evolving Digital World Laura Jenkins Jirele, Jeff Kirsch, Tom Jirele
Session 3: The World of Big Data from the Evolving Digital World Laura Jenkins Jirele, Jeff Kirsch, Tom Jirele PMSA Virtual University PMSA Virtual University is conducting this four part webinar series
More informationHow To Write an Effective Marketing Plan
How To Write an Effective Marketing Plan A Quick Start Guide for Avaya BusinessPartners + Plan + Use this guide to begin crafting a new future for your company. Execute Continue the Quick Start series
More informationHow To Transform Customer Service With Business Analytics
IBM Software Business Analytics Customer Service Transforming customer service with business analytics 2 Transforming customer service with business analytics Contents 2 Overview 2 Customer service is
More informationBusiness Intelligence and Pharmaceuticals. Major applications of business intelligence software in the pharmaceuticals industry
Business Intelligence and Pharmaceuticals Major applications of business intelligence software in the pharmaceuticals industry Business Intelligence and Pharmaceuticals 1. Introduction...2 2. The Pharmaceuticals
More informationDizz mobile phone case
2010 CASE STUDY Dizz mobile phone case Market overview Since mobile telephony was introduced in Europe in 1985, the market has grown at a far higher pace than was originally expected. Furthermore, mobile
More informationPHARMACEUTICAL SALES MANAGEMENT
PHARMACEUTICAL SALES MANAGEMENT SHARPENING CUSTOMER-CENTRIC STRATEGIES TO RESTORE ACCESS AND STRENGTHEN RELATIONSHIPS PUBLICATION DATE FEB. 2014 PAGES 195 CHAPTERS 4 THE BOTTOM LINE: New regulations and
More informationRETHINKING DIGITAL SELLING
RETHINKING DIGITAL SELLING BEST PRACTICES FOR MAXIMIZING RESULTS AND ROI Guiding Principles For Rethinking Your Digital Selling Strategy It s been nearly four years since reps started using tablet-based
More informationRichard T. Clark Chief Executive Officer and President. Executing on Our Strategy
Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS
More informationehealth 2.0: How health systems can gain a leadership role in digital health Gerardo Aue, Stefan Biesdorf, Nicolaus Henke
ehealth 2.0: How health systems can gain a leadership role in digital health Gerardo Aue, Stefan Biesdorf, Nicolaus Henke Health systems around the world clearly recognise the potential of digital health;
More informationActuarial Processes Delivering Business Performance Improvement Through Business Process Outsourcing
Business Transformation Services Consideration Brief Actuarial Processes Delivering Business Performance Improvement Through Business Process Outsourcing Table of Contents Executive Summary Client Background
More informationStatement BAR CODE LABEL REQUIREMENTS FOR HUMAN DRUG AND BIOLOGIC PRODUCTS
Statement on BAR CODE LABEL REQUIREMENTS FOR HUMAN DRUG AND BIOLOGIC PRODUCTS Edith Rosato, R.Ph. Vice President Pharmacy Affairs National Association of Chain Drug Stores Alexandria, VA July 26,2002 Submitted
More informationSpecialty Pharmacy? Disclosure. Objectives Technician
Disclosure What s so SPECIAL about? I have no actual or potential conflict of interest in relation to this program/presentation. Michael DeCoske, PharmD, BCPS Associate Chief Pharmacy Officer Duke University
More information57% Aligning content marketing with the buying cycle. Marketing has changed. of buyer's journey is complete before contacting sales 1
Aligning content marketing with the buying cycle Marketing has changed. From product reviews and service forums through to technical specs and comparison sites, it has never been easier for customers to
More informationWhat Tech Buyers Think TM
What Tech Buyers Think TM Who We Are Tech Buyer Perceptions, a division of the Perceptions Group, is a leader in providing the technology industry with research-based, tech buyer insight and data-driven
More informationTelemarketing Services Buyer's Guide By the purchasing experts at BuyerZone
Introduction: reasons to outsource The main reason companies outsource telemarketing operations is that setting up a large scale telemarketing call center is expensive and complicated. First you ll need
More informationAn Introduction to Valuations
An Introduction to Valuations PREPARED FOR ROCKY MOUNTAIN BIOBOOSTER MAY 9 TH, 2012 An ICON plc Company Agenda Introductions Valuation methods When is a valuation appropriate? How do you maximize your
More informationMain Title slide wording
EphMRA 2013 Pharmaceutical Market Research Conference Parallel Session 1 Main Title slide wording Turning the ocean liner using a few goes here speedboats and a great navigator Marion Wyncoll, Themis Analytics
More informationGreat Expectations: Why Pharma Companies Can t Ignore Patient Services
Accenture Life Sciences Rethink Reshape Restructure... for better patient outcomes Great Expectations: Why Pharma Companies Can t Ignore Patient Services Accenture Research Note: Key findings from a survey
More informationCustomer Experience Strategy and Implementation
Customer Experience Strategy and Implementation Enterprise Customer Experience Transformation 2014 Andrew Reise, LLC. All Rights Reserved. Enterprise Customer Experience Transformation Executive Summary
More informationAnnual General Meeting Business Update. William M. Tatham, CEO
Annual General Meeting Business Update William M. Tatham, CEO May 22, 2013 1 Disclaimer Certain statements in this presentation, including statements about the financial conditions, and results of operations
More informationMedAvail Technology Inc.
MedAvail Technology Inc. 1 Just as the ATM transformed the retail banking experience, MedAvail is transforming the prescription fulfilment experience 2 Quickly and easily fill prescriptions anytime, anywhere
More informationCMS-CMMI Releases Enhanced Medication Therapy Management (MTM) Model Test Beginning in January 2017
October 5, 2015 www.amcp.org CMS-CMMI Releases Enhanced Medication Therapy Management (MTM) Model Test Beginning in January 2017 Pursuant to a memorandum issued on September 28, 2015, the Centers for Medicare
More informationThe Hidden Value of Enterprise Content Management Deliver business value by leveraging information
The Hidden Value of Enterprise Content Management Deliver business value by leveraging information Introduction Enterprise Content Management (ECM) provides new information management tools, strategies
More informationBioPharma Analytics Informing every move
Specialty Solutions Insight Decisions Providers Payors Direction Patients BioPharma Analytics Informing every move Achieve market success faster with evidence-based market intelligence Cardinal Health
More informationPharmaceutical forecasts address critical business questions for all
S A L ES & M A R K E TI NG I N SIGHTS Understanding Your Brand s Performance: Creating Robust Forecasts by Integrating Commercial and Clinical Drivers Art Cook, Nisha Gilra and Eric Persoff Pharmaceutical
More informationOpen Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum
Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities
More informationGeneric and Brand Name Drugs: Understanding the Basics
Generic and Brand Name Drugs: Understanding the Basics We ve been there. We can help. Joe has just been diagnosed with bipolar disorder. After talking to his doctor, he decides to see a therapist and go
More informationIncrease Revenues with Channel Sales Management
Increase Revenues with Channel Sales Management Executive Summary Why is it so difficult to grow revenue, identify emerging customers and partners, and expand into new markets through the indirect sales
More informationPharmacy and Therapeutics Committee Policies and Procedures
Pharmacy and Therapeutics Committee Policies and Procedures I. Charter... p 2 II. Formulary Principles... p 3 III. Drug Review Process... p 4 7 A. When are Medications Reviewed B. How Are Medications Reviewed
More informationPHARMACY BENEFIT DESIGN CONSIDERATIONS
PHARMACY BENEFIT DESIGN CONSIDERATIONS Is your pharmacy benefit designed for your employees or the big drug companies? The pharmacy (or prescription) benefit is one of the most sought after benefits by
More informationLicensed Pharmacy Technician Scope of Practice
Licensed Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 Definitions In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationMARKET ACCESS SERVICES. Managed Markets Services
MARKET ACCESS SERVICES Managed Markets Services Table of contents 01 Your challenges 02 Your opportunities 03 Our services, your solutions 04 Advanced technology 05 Why Covance? 06 Get started... TOC 01
More informationPharmaceutical Sales Compensation
Past, Present and Future With highlights from the Towers Watson/Synygy Survey of Strategic Sales Incentive Plan Design and Governance in the Pharmaceutical Industry By Elliot Scott Past, Present and Future
More informationIt s a New World: Innovations in Oncology Data Analytics. By Mahmood Majeed and Prashant Poddar
It s a New World: Innovations in Oncology Data Analytics By Mahmood Majeed and Prashant Poddar It s a New World: Innovations in Oncology Data Analytics By Mahmood Majeed and Prashant Poddar Sales and marketing
More informationIs Your Marketing Head in the Cloud?
22 Oct 2012 Vol. 11, No. 9 Published by VirSci Corp. www.pharmamarketingnews.com www.virsci.com Is Your Marketing Head in the Cloud? The Appature Nexus Marketing Cloud Software Platform Author: John Mack
More information2016 Medicare Part D Transition Policy
Regulation/ Requirements Purpose Scope Policy 2016 Medicare Part D Transition Policy 42 CFR 423.120(b)(3) 42 CFR 423.154(a)(1)(i) 42 CFR 423.578(b) Medicare Prescription Drug Benefit Manual, Chapter 6,
More informationKey Indicators: An Early Warning System for Multichannel Campaign Management
Cognizant 20-20 Insights Key Indicators: An Early Warning System for Multichannel Campaign Management For pharmaceuticals companies, a careful analysis of both leading and lagging indicators for multichannel
More informationBuild Long-Term Customer Loyalty Achieve Lifetime Customer Value
Build Long-Term Customer Loyalty Achieve Lifetime Customer Value Revenue Cycle Management and Business Processing Solutions Rising Above Our Competitors A Different Kind of Partner HGS s Extended Business
More informationResearch Gamification for Quality Pharmaceutical Stakeholder Insights. White Paper. by Brian Mondry and Leah Fink March 2015
White Paper Catalysts driving successful decisions in life sciences. Research Gamification for Quality Pharmaceutical Stakeholder Insights by Brian Mondry and Leah Fink March 2015 www.kantarhealth.com
More informationPatent Expiry Impact Predictor
Patent Expiry Impact Predictor Compiled and written by Datamonitor plc Datamonitor plc (DTML) is a premium business information company specialising in industry analysis and providing clients with unbiased
More informationHealthcare, Regulatory and Reimbursement Landscape - Australia
Brochure More information from http://www.researchandmarkets.com/reports/2207850/ Healthcare, Regulatory and Reimbursement Landscape - Australia Description: Healthcare, Regulatory and Reimbursement Landscape
More informationPBM Revenue Generation Secrets HEALTHCARE ANALYTICS
PBM Revenue Generation Secrets HEALTHCARE ANALYTICS TODAY S AGENDA Brief background on the Prescription Benefits Manager (PBM) marketplace Basic Components of a PBM Contract How PBMs are exploiting contract
More informationAlgorithms and optimization for search engine marketing
Algorithms and optimization for search engine marketing Using portfolio optimization to achieve optimal performance of a search campaign and better forecast ROI Contents 1: The portfolio approach 3: Why
More informationSubmitted electronically to http://www.regulations.gov
Submitted electronically to http://www.regulations.gov Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-3288-NC P.O. Box 8016 Baltimore, MD 21244-8016 RE:
More information